Tacrolimus Treatment for Refractory PRCA

NCT03540472 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pure Red Cell Aplasia

Interventions

DRUG: tacrolimus

Sponsor

Peking Union Medical College Hospital